Mexico Blood-based Biomaker For Sports Medicine Market Size & Outlook
Mexico blood-based biomaker for sports medicine market, 2018-2030 (US$M)
Related Markets
Mexico blood-based biomaker for sports medicine market highlights
- The Mexico blood-based biomaker for sports medicine market generated a revenue of USD 17.6 million in 2023 and is expected to reach USD 24.4 million by 2030.
- The Mexico market is expected to grow at a CAGR of 4.8% from 2024 to 2030.
- In terms of segment, ck was the largest revenue generating type in 2023.
- CRP is the most lucrative type segment registering the fastest growth during the forecast period.
Blood-based biomaker for sports medicine market data book summary
| Market revenue in 2023 | USD 17.6 million |
| Market revenue in 2030 | USD 24.4 million |
| Growth rate | 4.8% (CAGR from 2023 to 2030) |
| Largest segment | Ck |
| Fastest growing segment | CRP |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | CK, Myoglobin, Lactate, WBC, Urea, CRP, Lipid and Protein Hydroperoxides, IL-6 |
Other key industry trends
- In terms of revenue, Mexico accounted for 2.6% of the global blood-based biomaker for sports medicine market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. blood-based biomaker for sports medicine market is projected to lead the regional market in terms of revenue in 2030.
- U.S. is the fastest growing regional market in North America and is projected to reach USD 425.8 million by 2030.
Ck was the largest segment with a revenue share of 18.18% in 2023. Horizon Databook has segmented the Mexico blood-based biomaker for sports medicine market based on ck, myoglobin, lactate, wbc, urea, crp, lipid and protein hydroperoxides, il-6 covering the revenue growth of each sub-segment from 2018 to 2030.
In Mexico, the incidence and mortality rates of cancer have risen in recent years. With the increasing participation in sports across Mexico, there has been a notable rise in sports-related injuries. In Mexico, around 39.8% of individuals participate in sports activities on a regular basis. This trend is expected to drive market growth in Mexico for blood-based biomarkers for sports medicine.
According to a UDCA study published in December 2021, a total of 74 injuries were reported, with 84% classified as nontraumatic. Among these, around 74% occurred during training, with 62 incidents during training and 55 incidents in total.
The injuries were primarily related to the Olympic 3-meter diving board, accounting for 51% of cases, while 22% affected the shoulder area and 34% involved tendon tissue. Most injuries were sustained by male athletes (57%) and those with less sporting experience (58%). Blood-based biomarkers offer a noninvasive method to detect & monitor various conditions, such as concussions and muscle injuries, enabling quicker and more accurate interventions.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Blood-based Biomaker for Sports Medicine Market Scope
Blood-based Biomaker for Sports Medicine Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Mexico blood-based biomaker for sports medicine market size, by type, 2018-2030 (US$M)
Mexico Blood-based Biomaker for Sports Medicine Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
